Quantitative and systems Pharmacology
However, some patients report: More consistent appetite suppression (likely due to standardized dosing) Fewer injection site reactions Better tolerability (if their compounded product had quality issues) If your compounded product used a salt form (semaglutide sodium, tirzepatide acetate, etc.), you might notice differences because you're now getting the FDA-approved base formulation
Researchers dont know why this might be, though previous research suggests that allulose regulates fat metabolism in mice
1 Currently, as per the evidence, an SGLT2 (sodium-glucose cotransporter 2) inhibitor and/or GLP-1(glucagon-like peptide 1) receptor agonist with proven CV (cardiovascular) benefit should be used in people with type 2 diabetes with established ASCVD (atherosclerotic cardiovascular disease) or indicators of high CV risk, established renal disease, or heart failure
This allowed the brand to avoid duplicating the supply issues it experienced when its injectable Wegovy was launched in 2021